EBMT 2016 | Graft-versus-host disease (GvHD): Advances at EBMT 2016

Mohamad Mohty

At the 42nd Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), held in Valencia, Spain, EBMT 2016 President Mohamad Mohty, MD, PhD, from Saint-Antoine Hospital, Paris, France, discusses graft-versus-host disease (GvHD), a complication that can occur after allogeneic transplantation and be a major barrier to the success of stem cell transplantation. Dr Mohty gives an overview of EBMT 2016 discussions, which address GvHD prophylaxis, pharmacologic agents and the role of polyclonal antibodies.

Share this video  
Similar topics